Evidence map›Paper›PMID 36185304›Full record

ArticleFrontiers in oncology2022

Survival nomogram for different grades of gastric cancer patients based on SEER database and external validation cohort.

Lei Hu, Kang Yang, Yue Chen, Chenyu Sun, Xu Wang, Shaopu Zhu, Shiyi Yang, Guodong Cao, Maoming Xiong, Bo Chen

Abstract read
In one paragraph

Article in Frontiers in oncology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Lei HuDepartment of General Surgery, The First Affiliated Hospital of Anhui Medical University, Hefei, China.
Kang YangDepartment of General Surgery, The First Affiliated Hospital of Anhui Medical University, Hefei, China.
Yue ChenDepartment of Clinical Medicine, School of the First Clinical Medicine, Anhui Medical University, Hefei, China.
Chenyu SunAMITA Health Saint Joseph Hospital Chicago, Chicago, IL, United States.
Xu WangDepartment of General Surgery, The First Affiliated Hospital of Anhui Medical University, Hefei, China.
Shaopu ZhuDepartment of General Surgery, The First Affiliated Hospital of Anhui Medical University, Hefei, China.
Shiyi YangDepartment of General Surgery, The First Affiliated Hospital of Anhui Medical University, Hefei, China.
Guodong CaoDepartment of General Surgery, The First Affiliated Hospital of Anhui Medical University, Hefei, China.
Maoming XiongDepartment of General Surgery, The First Affiliated Hospital of Anhui Medical University, Hefei, China.
Bo ChenDepartment of General Surgery, The First Affiliated Hospital of Anhui Medical University, Hefei, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Influencing factors varied among gastric cancer (GC) for different differentiation grades which affect the prognosis accordingly. This study aimed to develop a nomogram to effectively identify the overall survival (OS). Methods: Totally, 9,568 patients with GC were obtained from the SEER database as the training cohort and internal validation cohort. We then retrospectively enrolled patients diagnosed with GC to construct the external validation cohort from the First Affiliated Hospital of Anhui Medical University. The prognostic factors were integrated into the multivariate Cox regression to construct a nomogram. To test the accuracy of the model, we used the calibration curves, receiver operating characteristics (ROC) curves, C-index, and decision curve analysis (DCA). Results: Race chemotherapy, tumor size, and other four factors were significantly associated with the prognosis of Grade III GC Patients. On this basis, we developed a nomogram. The discrimination of the nomogram revealed good prognostic accuracy The results of the area under the curve (AUC) calculated by ROC for five-year survival were 0.828 and 0.758 in the training set and external validation cohort, higher than that of the TNM staging system. The calibration plot revealed that the estimated risk was close to the actual risk. DCA also suggested an excellent predictive value of the nomogram. Similar results were obtained in Grade-I and Grade-II GC patients. Conclusions: The nomogram developed in this study and other findings could help individualize the treatment of GC patients and assist clinicians in their shared decision-making with patients.

Indexed as

differentiation gradegastric cancernomogramprognosisseer

Identifiers

PMID36185304
PMCPMC9523147

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.